Answers are grounded in this paper and cite their sources.
We report a severe aplastic anemia occurring during the administration of osimertinib in a lung adenocarcinoma patient carrying EGFR T790M mutation.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: